Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
T1D Pregnancy & Me
NCT06959316 · View on ClinicalTrials.gov ↗
Study Summary
T1D Pregnancy \& Me will partner with pregnant participants living with type 1 diabetes (T1D) in the United States to collect real-world data on management of T1D in pregnancy. This is a remote study where participants can complete online surveys and share device data (continuous glucose monitor (CGM) data and insulin data). Through the collection of CGM, insulin, and pregnancy outcome data, the study will provide important information to understand how diabetes is being managed during pregnancy. These data will provide much needed evidence to guide modern management of diabetes during pregnancy with a goal of improving care and outcomes.
Conditions Studied
Interventions
- DEVICE Hybrid closed loop insulin delivery system
Study Locations (10)
Massachusetts
- Mass General Brigham — Boston
- Joslin Diabetes Center — Boston
Alabama
- University of Alabama at Birmingham — Birmingham
Colorado
- Barbara Davis Center for Diabetes & University of Colorado Health — Aurora
Florida
- Jaeb Center for Health Research — Tampa
Indiana
- Indiana University — Indianapolis
New York
- Icahn School of Medicine at Mount Sinai — New York
Ohio
- The Ohio State University — Columbus
Oregon
- Oregon Health and Science University — Portland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2025-04-25 |
| Est. Completion | 2027-04 |
Interested in This Trial?
Always speak with your doctor before enrolling in a clinical trial.
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06959316
The ClinicalTrials.gov registry entry for NCT06959316 describes a study currently listed as recruiting. It is categorized as an unspecified phase, which is the standard way researchers label where a study sits along the investigational pathway from early safety work through later efficacy and post-marketing evaluation. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Jaeb Center for Health Research, which has 134 total studies on file at ClinicalTrials.gov, and sponsors are the parties responsible for study design, oversight, and regulatory filings.
The record links to 4 conditions, with Diabetes Mellitus, Type 1 appearing as the primary indexed condition, and to 1 intervention — of which Hybrid closed loop insulin delivery system is the first listed. Interventions can include drugs, devices, procedures, behavioral programs, or observational arms, and each is tracked as a separate registry field so that downstream queries can filter accurately. When a trial lists multiple interventions, it usually reflects a multi-arm design or a comparison protocol rather than a single treatment being tested in isolation. The brief summary published in the registry is the clearest source of protocol intent and should be read before drawing conclusions from any sidebar tags.
Geographic footprint matters for practical reasons: NCT06959316 reports 10 study locations spanning 9 distinct geographic areas — top geographies include Massachusetts, Alabama, Colorado. A larger site network tends to correlate with broader recruitment capacity, but it does not imply anything about study quality, and site-level enrollment status can diverge from the overall registry status shown above. Every data point on this page comes from the public ClinicalTrials.gov dataset and is reproduced here for reference only; it is not a medical recommendation, an endorsement of the sponsor, or an invitation to enroll. Verify current status, eligibility criteria, and contact details directly at ClinicalTrials.gov, and discuss any participation decision with your own healthcare provider.
Frequently Asked Questions
What is clinical trial NCT06959316 about?
NCT06959316 is a clinical study titled "T1D Pregnancy & Me". T1D Pregnancy \& Me will partner with pregnant participants living with type 1 diabetes (T1D) in the United States to collect real-world data on management of T1D in pregnancy. This is a remote study where participants can complete online surveys and share device data (continuous glucose monitor (CG...
What is the current status of trial NCT06959316?
This trial is currently recruiting. The enrollment target is 500 participants. The study started on 2025-04-25. Estimated completion is 2027-04.
What conditions does trial NCT06959316 study?
This clinical trial studies the following conditions: Diabetes Mellitus, Type 1, Insulin Dependent Diabetes, Pregnancy, High-Risk, Pregnancy in Diabetics. These conditions were identified from the trial registry and reflect the primary focus areas of the research.
What interventions are being tested in trial NCT06959316?
The interventions under investigation include: Hybrid closed loop insulin delivery system (DEVICE). Each intervention is being evaluated for safety and efficacy as part of this clinical study.
Who is sponsoring clinical trial NCT06959316?
This trial is sponsored by Jaeb Center for Health Research, which has 134 total clinical trials registered on ClinicalTrials.gov. The sponsor is responsible for the study's design, funding, and regulatory compliance.
Where is trial NCT06959316 being conducted?
This trial has 10 study locations across Alabama, Colorado, Florida, Indiana, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How Clinical Trials Work
Understand phases 1-4, trial design, randomization, and the informed consent process.
Patient Rights in Clinical Trials
Your rights as a participant: consent, withdrawal, privacy, and who to contact.
Finding the Right Clinical Trial
A practical guide to searching trials, understanding eligibility, and evaluating options.
All Guides
Browse our complete library of clinical trial educational resources.
Read our methodology — how this data is sourced, computed, and verified.